Abstract: 20-HETE agonists and antagonists are disclosed along with therapeutic applications. In a preferable form of the invention, the 20-HETE agonists are selected from the group consisting of 21-hydroxyheneicosa-5(Z),8(Z),11(Z),14(Z)-tetraenoic acid, 20-hydroxyeicosa-5(Z),4(Z)-dienoic acid and 20-,21-dimethyl 20-HETE. Preferable 20-HETE antagonists include 5(S)-HETE, 15(S)-HETE, 19(S)-HETE, 19-hydroxynonadeca-5(Z),8(Z),11(Z),14(Z)-tetraenoic acid and 20-hydroxyeicosa 6(Z),15(Z)-dienoic acid.
Type:
Grant
Filed:
December 14, 2001
Date of Patent:
July 22, 2003
Assignee:
MCW Research Foundation
Inventors:
Richard J. Roman, John R. Falck, Magdalena Alonso-Galicia, Elizabeth R. Jacobs, David R. Harder
Abstract: The present invention discloses a new use of NO-releasing NSAIDs, especially NO-releasing NSAIDs of the formula I, or a pharmaceutically acceptable salt or enantiomer thereof, for the manufacture of a medicament for the treatment of bacterial infections, especially caused or mediated by Helicobacter pylon.
Disclosed is also the new use of a NO-releasing NSAID in combination with an acid susceptible proton pump inhibitor for the treatment of bacterial infections.
Abstract: Soft gelatin capsules having a capsule shell comprising gelatin, plasticizers and, if desired or required, further auxiliary agents, and a capsule filling containing a solvent including a migrateable solvent such as 1,2-propyleneglycol as a solvent in the capsule filling and in the capsule shell. The manufacture of said capsules is improved, if in the process for making the soft gelatin capsules the gelatin bands are cooled with a liquid, and preferably with water.
Type:
Grant
Filed:
February 7, 2000
Date of Patent:
July 8, 2003
Assignee:
Novartis AG
Inventors:
Werner Brox, Armin Meinzer, Horst Zande
Abstract: A medicinal formulation is disclosed. The formulation comprises (a) a protein or peptide medicament; (b) a fluid carrier for containing said medicament; and a stabilizer selected from an amino acid, a derivative thereof or a mixture of the foregoing.
Type:
Grant
Filed:
October 30, 2000
Date of Patent:
July 1, 2003
Assignee:
Aeropharm Technology Incorporated
Inventors:
Akwete L. Adjei, Yaping Zhu, John Z. Sun, Simon Stefanos
Abstract: Hair care compositions comprise a water-soluble polyalkylene glycol having a number average molecular weight of from about 200 to about 900 and from about 4 to about 18 repeating alkylene oxide radicals, wherein each of the repeating alkylene oxide radicals has from 2 to 6 carbon atoms; a film forming polymer is soluble in the polyalkylene glycol, wherein the weight ratio of the polyalkylene glycol to the film forming polymer ranges from about 5:1 to about 50:1; and a liquid carrier. The hair care compositions optionally further comprise a non-volatile silicone with a molecular weight greater than about 40,000 daltons.
Type:
Grant
Filed:
August 3, 2000
Date of Patent:
July 1, 2003
Assignee:
The Procter & Gamble Company
Inventors:
Jose Antonio Carballada, Dennis Eugene Kuhlman, Michael John Schneider
Abstract: The invention relates to hair compositions comprising, in a cosmetically acceptable medium, a polycondensate comprising at least one polyurethane and/or polyurea unit and a silicone comprising at least one carboxylic function. The invention is also directed towards a process for shaping or maintaining the hairstyle, comprising the use of these compositions, and to their use for the manufacture of hair products, in order to maintain or shape the hairstyle.
Abstract: An improved stick preparation is provided which is made up of at least two separate phases and at least one phase contains spherical polymer particles which can contain a pigment. The particles provide smoothness to the preparation and can be used to provide an interesting visual appearance to the stick.
Type:
Grant
Filed:
February 14, 2001
Date of Patent:
May 27, 2003
Assignee:
Henkel Kommanditgesellschaft auf Aktien
Inventors:
Bernhard Banowski, Wolfhard Scholz, Pascal Bordat, Marion Pöppl
Abstract: This invention relates to a medicinal aerosol formulation and more particularly, to a medicinal aerosol formulation containing a troglitazone medicament and a fluid carrier.
Abstract: Disclosed is a composition including a lower alcohol and water in a weight ratio of about 35:65 to 100:0, between at least 0.5% and 8.0% by weight thickener system comprised of at least two emulsifiers, each emulsifier present in at least 0.05% by weight wherein the composition free of auxiliary thickeners has a viscosity of at least 4,000 centipoise at 23 degrees C. and wherein each emulsifier is comprised of at least one hydrophobic group and at least one hydrophilic group. The composition is useful as a presurgical scrub replacement, a lotion or other hand preparation.
Type:
Grant
Filed:
December 10, 2001
Date of Patent:
May 13, 2003
Assignee:
3M Innovative Properties Company
Inventors:
Matthew T. Scholz, Robert A. Asmus, Jill R. Charpentier
Abstract: The present invention provides a method for preparing biodegradable porous polymer scaffolds for tissue engineering, comprising:
a) fabricating a polymer sample from a polymer solution containing at least one biodegradable polymer and an effervescent mixture;
b) effervescing the polymer sample in the presence of an effervescent medium such as an aqueous alcohol solution; and
c) drying.
The method for preparing biodegradable polymer scaffolds of the present invention has the advantages that the process is simple, that pore size can be easily controlled, that the problem caused by the secretion and existence of the toxic substance can be avoid by using a material harmless to human body, and that high efficiency can be achieved. In addition, biodegradable porous polymer scaffolds prepared by above method have the advantages that high porosity can be achieved and an open cell structure in which pores are interconnected is obtained.
Type:
Grant
Filed:
October 27, 2000
Date of Patent:
May 13, 2003
Assignee:
Korea Institute of Science and Technology
Inventors:
Dong Keun Han, Kwang-Duk Ahn, Jong-Man Kim, Young Min Ju
Abstract: The present invention relates to substantially uniform, discontinuous films of a skin care product having a defined average particle size, particle spacing and coverage value. The films provide improved skin appearance, e.g., good apparent coverage and a natural look. The films can be formed by any method which provides the defined particle size, particle spacing and coverage value, including silk screening and the like and electrostatic spray techniques. The films are preferably formed by electrostatically spraying the composition onto the skin.
Type:
Grant
Filed:
April 25, 2002
Date of Patent:
May 6, 2003
Assignee:
The Procter & Gamble Company
Inventors:
Helen Shu Ying Yen, Thomas Elliot Rabe, Jeffrey Keith Leppla, Robert Lawrence Prosise
Abstract: A pharmaceutical preparation for the treatment of wounds and ulcers in humans and animals and a method of preparation of the same are provided here. The composition consists of an alcoholic extract of Huangqin, Huanglian, Huangbai, Opuntia, Dilong, and &bgr;-sitosterol (from Soybean extract), in a vegetable oil-wax base, from where the alcohol is essentially removed by evaporation. The composition is used as a topical ointment for the treatment of wounds in its preferred embodiment. Wounds, in particular those occurring in the skin as second and third degree burns, stasis ulcers, trophic lesions, such as decubitus ulcers, diabetic ulcers, surgical wounds, severe cuts, diaper rash, cracked nipples and abrasions which are commonly resistant to the natural healing process, may be treated with this composition.
Abstract: This invention relates to a medicinal aerosol formulation and more particularly, to a medicinal aerosol formulation containing pioglitazone medicament and a fluid carrier.
Type:
Grant
Filed:
October 31, 2000
Date of Patent:
April 15, 2003
Assignee:
Aeropharm Technology Incorporated
Inventors:
Anthony J. Cutie, Akwete L. Adjei, Frederick A. Sexton
Abstract: Methods and compositions are disclosed for prevention and/or treatment of diseases in which 5- and 12-lipoxygenase activity contributes to the pathological condition, by administration of 12-methyletradecanoic acids alone and in conjunction with other therapeutic compounds. Methods to inhibit lipoxygenase-mediated inflammations are disclosed.
Type:
Grant
Filed:
April 6, 2001
Date of Patent:
April 1, 2003
Assignee:
Coastside Bio Resources
Inventors:
Peter D. Collin, Peiying Yang, Robert Newman
Abstract: This invention relates to a medicinal aerosol formulation and, more particularly, to a medicinal aerosol formulation an insulin combination and a fluid carrier.
Abstract: This invention relates to a medicinal aerosol formulation and more particularly, to a medicinal aerosol formulation containing a &bgr;-cell hypoglycemic agent and a fluid carrier.
Type:
Grant
Filed:
October 31, 2000
Date of Patent:
April 1, 2003
Assignee:
Aeropharm Technology Incorporated
Inventors:
Akwete L. Adjei, Anthony J. Cutie, John Z. Sun, Fred Sexton
Abstract: A gel composition for use in etching the surfaces of teeth in preparation for prophylaxis, repair, or restoration, comprising an aqueous solution of an effective quantity of an acid; and a colloidal silica sol, wherein the silica portion of the sol comprises from about 3 to about 20 weight percent of the total etchant composition.
Abstract: Cosmetic skin care methods and compositions containing carboxymethylates of branched alcohols and/or ethoxylates thereof. The inventive compositions provide control of sebum secretion from sebocytes, improved oil control and improved skin feel, prevent shine and stickiness, while also providing anti-aging benefits which results in reduced appearance of wrinkles and aged skin, improved skin color, treatment of photoaged skin, improvement in skin's radiance and clarity and finish, and an overall healthy and youthful appearance of the skin.
Type:
Grant
Filed:
June 1, 2001
Date of Patent:
March 18, 2003
Assignee:
Unilever Home & Personal Care USA division of Conopco,
Inc.
Inventors:
Bijan Steven Harichian, Laurence Boen, John Steven Bajor
Abstract: Disclosed are stabilized electrostatically-sprayable topical compositions and methods of treating the skin by electrostatic application of such compositions. The compositions comprise:
a) from about 2% to about 90% of a liquid insulating material;
b) from about 2% to about 90% of a conductive material;
c) from about 0.1% to about 35% of a particulate material which is insoluble and immiscible in the composition; and
d) from about 0.5% to about 30% of a thickener for stabilizing the composition.
The liquid insulating materials and conductive materials present in the composition are sufficiently miscible or soluble in the composition such that they are in substantially one phase.
Type:
Grant
Filed:
July 31, 2000
Date of Patent:
March 11, 2003
Assignee:
The Procter & Gamble Company
Inventors:
Thomas Elliot Rabe, Helen Shu Ying Yen, Spiros Aristotle Nicols
Abstract: Process for moulding a make-up composition in a mould comprising a concave moulding surface forming the base of the mould and a bottom forming the upper component of the mould and closing off the space bounded by the said moulding surface, the composition being cast in the said mould in fluid form and subsequently solidifying to form a demouldable solid product capable of being packaged, in which the said composition is cast in a mould (1) whose bottom consists at least partly of a sheet (2) of open-cell plastic foam, so as partly to impregnate the said foam sheet (2) with the said composition and in which, after solidifying of the said composition, a moulded product consisting of the solidified composition and of the foam sheet which is bonded to it and which forms its support, is demoulded by removing the moulding surface (1).